Tailor Made Compounding
Contact pharmacy ↗ Request an introduction ↗A Kentucky-based patient-specific 503A compounding pharmacy focused on HRT, peptides, and weight management, licensed across most states.
This profile is editorial. PeptideWellness has no commercial relationship with this pharmacy; coverage and assessment are never for sale.
Tailor Made is a patient-specific 503A compounding pharmacy — meaning it prepares medications against individual prescriptions rather than manufacturing office-use batches as a 503B outsourcing facility would.
Facility & accreditation
Tailor Made is a 503A pharmacy; it does not appear on the FDA Registered Outsourcing Facilities (503B) list [1], and its own site repeatedly describes itself as a “patient-specific 503A compounding pharmacy” [2]. Its site displays an NABP Verified Pharmacy Program badge and notes oversight by state boards (Kentucky and California) [2] — the company’s own statements. Independently, a search of ACHC’s PCAB directory returned no PCAB accreditation for Tailor Made [3], and NABP publishes no self-service registry we could check, so the NABP badge is unconfirmed from the accreditor’s own source. The site states it is “licensed in 46 states for both sterile and nonsterile compounding” (one homepage graphic inconsistently reads “48 states”; the 46 figure appears in body copy) [2].
What they compound
Explicitly “from HRT to peptide therapies,” plus men’s and women’s health, weight management, anti-aging, and IV therapy [2]. Specific named GLP-1 (semaglutide/tirzepatide) product listings were not confirmed from the pages we reviewed.
Regulatory record
On April 1, 2020 the FDA sent Tailor Made a warning letter after an inspection of its Nicholasville pharmacy from August 20 to October 24, 2018 [4]. FDA has since taken the letter off its website; the link is to the Internet Archive’s copy of the FDA page. The letter found that the pharmacy had compounded drugs from bulk substances that are not eligible for compounding under 503A, among them BPC-157, AOD-9604, CJC-1295, ipamorelin, GHK-Cu, PT-141, epitalon, selank, semax, cerebrolysin and melanotan II. It also describes insanitary conditions in sterile production, CGMP violations, an injectable glutathione whose strength differed from its label, and a recall of tesamorelin vials labelled with the wrong beyond-use date. FDA’s list of compounding actions records a later Form 483, issued March 14, 2022 [5].
Tailor Made is not on the FDA 503B list [1].
The read
A mid-size 503A pharmacy with wide state licensure and a clear HRT/peptide/weight-management focus. Its 2020 warning letter is specifically about peptides: FDA said a long list of them could not be compounded under 503A at the time. As a state-regulated 503A (not a 503B outsourcing facility), it fits practices ordering patient-specific prescriptions rather than bulk office stock.
References
- FDA — Registered Outsourcing Facilities (503B) list. (accessed 2026-07-01)
- Tailor Made Compounding — official site. (accessed 2026-07-01)
- ACHC / PCAB accredited-organization directory (searched “Tailor Made”). (accessed 2026-10-27)
- FDA — Warning letter to Tailor Made Compounding LLC, MARCS-CMS 594743, April 1, 2020 (Internet Archive copy of the FDA page). (accessed 2026-10-21)
- FDA — Compounding: Inspections, Recalls, and other Actions (TMC Acquisitions, LLC dba Tailor Made Compounding entry). (accessed 2026-10-21)